Clinical Outcomes and Statistical Analysis

Cross-source consensus on Clinical Outcomes and Statistical Analysis from 1 sources and 5 claims.

1 sources · 5 claims

Other

Highlighted claims

The primary outcome is the proportion of patients aged 65 or older receiving at least one targeted potentially inappropriate medication at 12-month follow-up. — Study protocol for a hybrid I randomised clinical trial to evaluate an audit and feedback and a pharmacist-led intervention to reduce potentially inappropriate medications in older adults: the AIM study
All analyses use the intention-to-treat principle, retaining general practitioners in their assigned groups regardless of adherence. — Study protocol for a hybrid I randomised clinical trial to evaluate an audit and feedback and a pharmacist-led intervention to reduce potentially inappropriate medications in older adults: the AIM study
Secondary outcomes include drug-class-specific prescribing proportions and RE-AIM implementation measures. — Study protocol for a hybrid I randomised clinical trial to evaluate an audit and feedback and a pharmacist-led intervention to reduce potentially inappropriate medications in older adults: the AIM study
Primary effectiveness is analysed with generalised mixed models adjusted for baseline prescriptions and general practitioner characteristics. — Study protocol for a hybrid I randomised clinical trial to evaluate an audit and feedback and a pharmacist-led intervention to reduce potentially inappropriate medications in older adults: the AIM study
Missing outcome data are handled with multiple imputation by chained equations using 50 imputed datasets. — Study protocol for a hybrid I randomised clinical trial to evaluate an audit and feedback and a pharmacist-led intervention to reduce potentially inappropriate medications in older adults: the AIM study